Mariko D. DeWire-Schottmiller, MD, completed her graduate medical training at the Boonshoft School of Medicine at Wright State University, residency training in pediatrics at Lebonheur Children's Medical Center, and pediatric hematology/oncology training at St. Jude Children's Research Hospital in Memphis, Tennessee, with a focus on pediatric neuro-oncology.

Dr. DeWire-Schottmiller's clinical and academic interests pertain to children and families affected by central nervous system tumors. She is a member of the Central Nervous System (Brain Tumor) Committee in the Children's Oncology Group (COG) as well as the Cincinnati Children's co-principal investigator for the Pediatric Brain Tumor Consortium (PBTC).

PI of Clinical Trial:  NCT 03387020

Dr. Mohamed S. AbdelBaki is a pediatric neuro-oncologist at Nationwide Children's Hospital (NCH) and an assistant professor of Pediatrics at The Ohio State University. Dr. AbdelBaki is responsible for developing phase I trials for brain tumors at NCH, and he is the principal investigator for several national clinical trials investigating novel therapies in pediatric neuro-oncology. Dr. AbdelBaki did his pediatric neuro-oncology fellowship training at one of the largest brain tumor programs in the country: Texas Children's Hospital-Baylor College of Medicine. 

From 2013 through 2015, Dr. AbdelBaki served as the director of the Pediatric Neuro-Oncology Program at Cardinal Glennon Children's Medical Center, Saint Louis University. In 2015, Dr. AbdelBaki received the Saint Louis University School of Medicine Distinguished Teaching Award, and in 2016, he received the Family Centered Care Award from NCH. He is a member of the Central Nervous System Committee in the Children's Oncology Group (COG) as well as the NCH principal investigator for the Pediatric Pacific Neuro-Oncology Consortium (PNOC).

Investigator of Clinical Trial:  MV-NIS (NCT 02962167)

Jonathan L. Finlay, MB, ChB, FRCP, FRCPCH, is the Program Director of Neuro-Oncology at Nationwide Children's Hospital and the Elizabeth and Richard Germain Chair in Pediatric Cancer. Dr. Finlay is a tenured Professor of Pediatrics at The Ohio State University College of Medicine. He is an internationally recognized expert in pediatric brain tumors and has authored or co-authored over 250 peer-reviewed publications in leading medical journals and over 80 review articles and book chapters. The focus of Dr. Finlay’s  research for over 30 years has been improving the cure and quality of survival of young children with newly-diagnosed malignant brain tumors (medulloblastoma and other CNS embryonal tumors such as AT/RT) through avoidance or at least minimization of radiation therapy. This has been accomplished  through the “Head Start” prospective, multi-national clinical trials incorporating marrow-ablative chemotherapy and autologous blood cell rescue which he initiated back in 1991.

Prior to coming to Nationwide Children's, Dr. Finlay was the Director of the Neural Tumors Program at Children's Hospital Los Angeles and served as Professor of Pediatrics, Neurology & Neurological Surgery at the Keck School of Medicine, University of Southern California. Between 1982 and 2003, he held faculty positions in Pediatric Oncology at Stanford University (1980-1982), University of Wisconsin-Madison (1982-1987), University of Pennsylvania (1987-1989), Cornell University/Memorial Sloan-Kettering Cancer Center (1989-1993) and New York University (1997-2003).

Investigator of Clinical Trial:  MV-NIS (NCT 02962167)